The up-regulation of PKM2-induced chemoresistance frequently occurs in breast cancer, particularly in relation to TAM, DOX, and ADR resistance (Wang et al. 2021b; Yu et al. 2020; Qian et al. 2018). The gene discussed is PKM; the disease is breast carcinoma.